Viewing Study NCT03481205


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-01-04 @ 9:47 PM
Study NCT ID: NCT03481205
Status: RECRUITING
Last Update Posted: 2025-11-07
First Post: 2018-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ischemic Conditioning During Air tRansport Save penUmbral Tissue
Sponsor: Enrique Leira
Organization:

Study Overview

Official Title: Ischemic Conditioning During Air tRansport Save penUmbral Tissue
Status: RECRUITING
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ICARUS
Brief Summary: The purpose of this study is to demonstrate the feasibility of performing remote limb ischemic conditioning (RLIC) using the Doctormate device, a special blood pressure device used to perform RLIC, on patients with acute ischemic stroke due to large vessel occlusion being transported to a thrombectomy capable center by the helicopter.
Detailed Description: In this study, 15 subjects presenting to a community hospital with signs and symptoms of ischemic stroke due to large vessel occlusion, transported to a comprehensive stroke center by aircew will receive RLIC using the Doctormate device.

The RLIC treatment will consist of 3-5 cycles ( depending on transportation time) of 5 minutes inflations of both blood pressure cuffs simultaneously. Blood pressure will be 200 mm HG with 5 minutes of reperfusion between each inflation.

Subjects will be evaluated upon arrival to the comprehensive stroke center and evaluated for side effects.

The study will be conducted at one site ( University of Iowa Hospitals and Clinics)

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: